NewsBenzingaOuster第三季度每股收益（EPS）为$(0.20)，优于预期的$(0.24)；销售额为5932.5万美元，超过预期的5626.7万美元 Ouster第三季度每股收益（EPS）为$(0.20)，优于预期的$(0.24)；销售额为5932.5万美元，超过预期的5626.7万美元 Benzinga 2026.11.03 21:10 (GMT+0) Open on Benzinga Other news Wedbush Maintains Outperform on Spyre Therapeutics, Lowers Price Target to $120 Autolus Therapeutics To Present Clinical Update Abstracts At American Society of Hematology Meeting, December 12-15 Wedbush Maintains Neutral on Ultragenyx Pharmaceutical, Lowers Price Target to $22 Magic Empire Global Secures $100M Facility From Anyu International To Finance Its Timber Supply Chain Trading Operations Wedbush Maintains Outperform on Denali Therapeutics, Raises Price Target to $24 Conference call: Stanley Black & Decker Sees FY 2026 Sales expected to be flat YoY
Autolus Therapeutics To Present Clinical Update Abstracts At American Society of Hematology Meeting, December 12-15
Magic Empire Global Secures $100M Facility From Anyu International To Finance Its Timber Supply Chain Trading Operations
